Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix said: "We are excited to expand our strategic partnership with Boehringer Ingelheim, a recognized leader and innovator in this field, with whom ...

As Chief Medical Officer, Dr. Steinhubl will help drive Eko’s clinical strategy, research initiatives, and external scientific collaborations, further strengthening the evidence base and accelerating ...

The results were presented at Charing Cross 2026 by Dr. Andrew Holden during a session on Abdominal Aortic Aneurysm (AAA) disease management Nectero Therapeutics, a clinical-stage biotechnology ...

The Series A round was led by family offices, trusts, and individual investors, a group with deep expertise across biotechnology, regenerative medicine, and healthcare innovation. PranaX Corporation, ...

Recommended employer actions include need for disruption, heightened scrutiny of vendor partners, sharper focus on preventive care and chronic condition management The escalating cost of health care ...

Chris Green writes, "I am often asked how AI will transform conducting medical and pharmaceutical inventory. Some have asked me will it replace human workers? Will everything be automated? Is it more ...

In this ever-changing healthcare landscape, prioritizing data-driven decision-making and proactively adopting advanced technologies will position health systems to achieve lasting success in 2026 and ...

Avania will evolve, invest, and pivot with the industry so it can achieve its mission of partnering with MedTech sponsors to bring life-changing technology to market, resulting in improved healthcare ...

As America’s population ages, the demand for assisted living facilities (ALFs) continues to rise. But while the need is national, the opportunity is not evenly distributed. Developers, investors, and ...

16.3.25. Zenith Sales & Calibrations Pty Ltd.

The funding will accelerate Earendil Labs' AI-driven R&D platform, expand its interdisciplinary teams, and advance a growing pipeline of antibody and biologics programs, with the goal of delivering ...

Under the terms of the agreement, Lilly will acquire Kelonia, and Kelonia shareholders will receive up to $7.00 billion in cash, inclusive of an upfront payment of $3.25 billion, and subsequent ...